Soleno Therapeutics, Inc. Common Stock (SLNO)
Soleno Therapeutics (SLNO) faces social media concerns over trial endpoints, impacting its market dominance near a 52-week low despite positive analyst ratings and acquisition rumors.
About Soleno Therapeutics, Inc. Common Stock
Soleno Therapeutics, Inc. Common Stock is a pharmaceutical company focused on developing treatments for rare diseases.
Soleno Therapeutics, Inc. Common Stock uses the ticker $SLNO for trading. Listed in the Stocks category.
Insights
- Soleno Therapeutics, Inc. Common Stock (SLNO) market dominance near a 52-week low at [-------].
- Soleno Therapeutics, Inc. Common Stock (SLNO) social dominance is up 1500% from the previous week.
- Soleno Therapeutics, Inc. Common Stock (SLNO) creators is up 46.75% from the previous month.
- Soleno Therapeutics, Inc. Common Stock (SLNO) engagements is up 75.74% from the previous week.
- Soleno Therapeutics, Inc. Common Stock (SLNO) mentions is up 41.36% from the previous month.
Price: $37.20
Price 24-Hour Time-Series Raw Data
The stock price has decreased recently, nearing a 52-week low, primarily due to social media concerns regarding trial endpoints, which have outweighed positive analyst ratings and acquisition rumors.
24-Hour: -3.8% 7-Day: -8.64% 30-Day: -12.34%
1-Year High: $88.50 on 2025-07-09
1-Year Low: $37.20 on 2026-02-13
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
Soleno Therapeutics, Inc. Common Stock (SLNO) is currently AltRank #713 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] +323
[--] Months: [---] +412
1-Year High: [-----] on 2025-07-27
1-Year Low: [--] on 2025-11-06
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
1-Year High: [--] on 2025-05-15
1-Year Low: [--] on 2025-09-15
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [------] +76%
[--] Month: [-------] -59%
[--] Months: [---------] +94%
[--] Year: [---------] +402%
1-Year High: [-------] on 2025-11-04
1-Year Low: [---] on 2025-06-01
Engagements by network (24h): TikTok: [--] Reddit: [---] News: [--] X: [-----] YouTube: [--] Instagram: [--]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +16%
[--] Month: [---] +41%
[--] Months: [-----] +24%
[--] Year: [-----] +342%
1-Year High: [---] on 2025-11-08
1-Year Low: [--] on 2025-09-06
Mentions by network (24h): TikTok: [--] Reddit: [--] News: [--] X: [---] YouTube: [--] Instagram: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Soleno Therapeutics, Inc. Common Stock (SLNO) in the last [--] hours which is down 46% from [---] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] +14%
[--] Month: [---] +47%
[--] Months: [---] -27%
[--] Year: [-----] +202%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-02-28
The most influential creators that mention Soleno Therapeutics, Inc. Common Stock in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @seedy19tron | [--] | [------] | [--] | [---] |
| @BOSSTRADING0 | [--] | [-----] | [--] | [---] |
| @Pharmdca | [--] | [-------] | [--] | [---] |
| @ScorpionFund | [--] | [------] | [--] | [---] |
| @yoldash718 | [--] | [---] | [--] | [---] |
| @NightOwlBiotech | [--] | [-----] | [--] | [--] |
| @jmli19698 | [--] | [--] | [--] | [--] |
| @tunemusicalmoments | [--] | [---------] | [--] | [--] |
| @WexCapital | [--] | [-----] | [--] | [--] |
| @FRlyeh75577 | [--] | [--] | [--] | [--] |
Sentiment: 64%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 64%
Daily Average: 79%
[--] Week: 46% -21%
[--] Month: 61% -4%
[--] Months: 61% -3%
[--] Year: 61% -25%
1-Year High: 100% on 2025-03-02
1-Year Low: 22% on 2025-09-10
Most Supportive Themes:
- Goldman Sachs Initiates Buy Rating: (10%) Goldman Sachs has initiated coverage of Soleno Therapeutics with a Buy rating, signaling positive institutional sentiment.
- Competitor Setback: (15%) A competitor's setback in a similar therapeutic area is likely contributing to positive market share gains for Soleno Therapeutics.
- Acquisition Rumors: (20%) Speculation about potential acquisition of Soleno Therapeutics is circulating, driven by rumors and analyst reports, suggesting investor interest.
Most Critical Themes:
- Recent Price Decrease: (5%) The stock price has experienced a decrease in the last [--] hours, indicating recent negative price action.
- Negative Sentiment Shift: (10%) Despite overall positive sentiment, recent negative sentiment and a price decrease suggest potential volatility and a possible correction.
Social Dominance: 0.0088%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0088%
Daily Average: 0.014%
[--] Week: 0.136% +0.128%
[--] Month: 0.024% -0.001%
[--] Months: 0.024% +0.0086%
[--] Year: 0.024% +0.016%
1-Year High: 0.066% on 2025-03-28
1-Year Low: 0.0037% on 2025-12-27
Market Dominance: 0.00228%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00228%
Daily Average: 0%
1-Year High: 0.015% on 2025-03-31
1-Year Low: 0.00227% on 2026-02-15
Market Cap: $2,008,754,935
Market Cap 24-Hour Time-Series Raw Data
Current Value: $2,008,754,935
Daily Average: $3,328,321,254
[--] Week: $2,008,754,935 -8.20%
[--] Month: $2,000,161,331 -12%
[--] Months: $2,000,161,331 -45%
1-Year High: $4,667,570,703 on 2025-07-09
1-Year Low: $2,000,161,331 on 2026-02-13
Top Soleno Therapeutics, Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"DEEP TRACK UPDATES 13F $XBI $IBB NEW POSITIONS: $VERA $GRAL $MLTX $ALKS $CNTA $SLNO $VSTM $ENTA $ATAI $COGT $NMPR $BLLN $IVA $JANX $ANL INCREASED $IMVT $TARS $AXSM $PCVX $MAZE $BMRN $NRIX $MBX $IMCR $CRMD $DYN $BCAX $ENGN $ANIP $DFTX $TNGX $XFOR $HELP"
X Link @BOSSTRADING0 2026-02-14T16:40Z [----] followers, [----] engagements
"$SLNO with that balance sheet does not even need $1b+ sales to be a great investment by historical standards. We shall see. $XBI"
X Link @belowcashbuyer 2026-02-14T15:01Z [---] followers, [---] engagements
"No update for a bit lets talk: This year Im modifying my approach and will be focusing on high conviction plays and holding a significant cash stack. I am about 70% cash currently and holding onto it for good opportunities. I closed a vast majority of my positions but I wont spend too much time on those in this post. Here is where I currently stand: Long: $BBIO $CRNX $SLNO These are long term holds. I intend to hold onto both $BBIO and $CRNX for years to come and I think both have fantastic potential as long as they continue to execute. $BBIO is my largest position by quite a bit and I have"
X Link @augurbio 2026-02-14T03:10Z [---] followers, [----] engagements
"@seedy19tron $SLNO trades like death but the word inside the PWS community slants positive. Time will tell but if what I'm hearing is true it should explode to the upside at some point"
X Link @MBbiotech 2026-02-13T21:04Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing